Table 2.
Significant covariates | p value | Beta value |
---|---|---|
Ratio of proteins to total calories (g/cal) * phase 2 | 0.0071 | 10.95 |
Ratio of lipids to total calories (g/cal) * phase 2 | 0.0437 | 5.658 |
Phase 2 | 0.0003 | − 0.7766 |
Calories/kilogram past week | < 0.0001 | − 0.626 |
Proportion of calories enteral | < 0.0001 | − 0.5566 |
Corticosteroids past week * phase 1 | 0.0035 | 0.3669 |
Diuretics past week * phase 1 | 0.0002 | 0.3393 |
Diuretics past week * phase 2 | < 0.0001 | 0.3306 |
Motility agents past week * phase 2 | 0.0003 | − 0.3144 |
Diuretics past week | < 0.0001 | − 0.2266 |
Antibiotics past week | < 0.0001 | − 0.2176 |
Motility agents past week | 0.0087 | 0.1522 |
Gestational age at birth | 0.0165 | 0.059 |
Multiple regression associations of weight Z-score (as the outcome variable) with microbiome phase, nutrition, and other clinical covariates, as well as the interactions between phases and clinical covariates (interaction terms denoted with an asterisk). P values indicate the significance of each association while beta values indicate the direction and magnitude of the relationship between weight Z-score and the covariates